OvuCon
In-home Ovulation Prediction
Health Tech & Life Sciences
Non Active, Nov 2019 ceased to operate
Company Overview
Snapshot
Founded in May 2015 by Simon Dotan and Gidon Zundelevich, OvuCon operated with 1–10 employees. The company ceased operations in November 2019.
Business overview
OvuCon developed an over-the-counter medical device for accurate ovulation prediction, targeting couples seeking to conceive by identifying the woman's fertile period. The company's core technology involved a proprietary sensor and algorithms designed to predict ovulation and provide a five-day fertile window, accessible via a mobile phone. Operating within the Health Tech & Life Sciences sector, specifically Digital Healthcare and Medical Devices, OvuCon aimed to serve patients and consumers in the fertility and women's health markets.
Company Intelligence Q&A
- What is OvuCon's primary offering?
- OvuCon offers an over-the-counter medical device designed to accurately predict ovulation, helping couples identify the woman's fertile period for conception.
- When was OvuCon founded and by whom?
- OvuCon was founded in May 2015 by co-founders Simon Dotan and Gidon Zundelevich.
- What technology powers OvuCon's device?
- OvuCon's device is powered by a proprietary sensor and a set of algorithms that accurately predict ovulation and provide a five-day fertile window, integrated with mobile phone access.
- What was the outcome of the proof of concept study for OvuCon's product?
- A proof of concept conducted in Hadassah Medical Center with 42 participants confirmed OvuCon's product could identify a pattern of cervical mucus, with the fertile period detected by the algorithm starting on the second day after the peak and ending one day after the nadir.
- What is OvuCon's operational status?
- OvuCon is currently non-active, having ceased to operate in November 2019.